MedTrace Logo

Effectiveness of the Diaphragm for HIV Prevention

NCT00121459 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2015-03-04

No results posted yet for this study

Summary

The purpose of this trial is to determine whether using the diaphragm and a lubricant get can reduce women's risk of acquiring an HIV infection.

Conditions

  • HIV Infection

Interventions

DEVICE

Ortho All-Flex diaphragm and Replens lubricant gel

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Ibis Reproductive Health

    collaborator OTHER

  • Medical Research Council, South Africa

    collaborator OTHER

  • Women's Health Global Imperative

    collaborator UNKNOWN

  • UZ-UCSF Collaborative Research Programme

    collaborator OTHER

  • Perinatal HIV Research Unit of the University of the Witswatersrand

    collaborator OTHER

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Nancy Padian, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30

Countries

  • South Africa
  • Zimbabwe

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00121459 on ClinicalTrials.gov